Chlamydia Vaccine Clinical Trial.

This clinical trial is assessing whether an investigational vaccine can safely and effectively prevent chlamydia infections among young adults.

The study is being conducted at our Brisbane and Canberra clinics.

Apply Now

Help Us Study Potential Vaccines for Flu, RSV, hMPV, and PIV3: A Research Opportunity for Adults 18–49.

Paratus Clinical are conducting a trial evaluating new potential vaccines for respiratory illnesses like the flu, RSV, hMPV, and PIV3. If you’re aged 18 to 49 and healthy, you may be eligible to participate in this 6-month study. Reimbursement will be provided for participation.

This study is being conducted at our Western Sydney and Brisbane clinics.

New GSK Asthma Study- Evaluating an experimental inhaler propellant

A Phase 3 study investigating the efficacy and long-term safety of the experimental, modified inhaler with a climate friendly propellant HFA-152a in comparison to the currently approved inhaler with propellant HFA-134a in participants aged 18 years and over with diagnosed asthma.

This study is being being conducted at our Central Coast site

RSV/hMPV Vaccine Study with Paratus

A Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.

This study is being conducted at our Brisbane site.